Clinical trialNCT06439836RecruitingPhase 1Interventional

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

SponsorNational Cancer Institute (NCI)Enrollment27Metastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Matthew D Galsky
MOUNT SINAI HOSPITAL
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Comprehensive Cancer Center
Duarte, California, United States
Abhishek Tripathi
Recruiting
Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
Nataliya Mar
Recruiting
Uc San Diego Moores Cancer Center
La Jolla, California, United States
Tyler Stewart
Recruiting
Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
Nataliya Mar
Recruiting
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Jaime R. Merchan
Recruiting
Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
Jacqueline T. Brown
Recruiting
Emory University Hospital Midtown
Atlanta, Georgia, United States
Jacqueline T. Brown
Recruiting
Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
Jacqueline T. Brown
Recruiting
Mount Sinai Hospital
New York, New York, United States
Matthew D. Galsky
Recruiting
Nyp/weill Cornell Medical Center
New York, New York, United States
Rohit Jain
Recruiting
Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Waddah Arafat
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 May 2025
Primary completion: 1 Jun 2027
Completion: 1 Jun 2027
Last update posted: 1 Jul 2026
Registered enrollment: 27
Registry id: NCT06439836

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.